Inactivation of Human Immunodeficiency Virus Type 1 by Ozone In Vitro

A device was designed to deliver a constant source of given concentrations of ozone to fluids containing human immunodeficiency virus type 1 (HIV-1). Ozone was found to inactivate HIV-1 virions in a dose-dependent manner. Greater than 11 log inactivation was achieved within 2 hours at a concentratio...

Full description

Saved in:
Bibliographic Details
Published inBlood Vol. 78; no. 7; pp. 1882 - 1890
Main Authors Wells, Keith H., Latino, Joseph, Gavalchin, Jerrie, Poiesz, Bernard J.
Format Journal Article
LanguageEnglish
Published Washington, DC Elsevier Inc 01.10.1991
The Americain Society of Hematology
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A device was designed to deliver a constant source of given concentrations of ozone to fluids containing human immunodeficiency virus type 1 (HIV-1). Ozone was found to inactivate HIV-1 virions in a dose-dependent manner. Greater than 11 log inactivation was achieved within 2 hours at a concentration of 1, 200 ppm ozone. Similar concentrations of ozone had minimal effect on factor VIII activity in both plasma and immunoaffinity-purified preparations of factor VIII treated for the same time period. The data indicate that the antiviral effects of ozone include viral particle disruption, reverse transcriptase inactivation, and/or a perturbation of the ability of the virus to bind to its receptor on target cells. Ozone treatment offers promise as a means to inactivate human retroviruses in human body fluids and blood product preparations.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
None
ISSN:0006-4971
1528-0020
DOI:10.1182/blood.V78.7.1882.1882